bioRxivCell BiologyPreprint
Heart generation via blastocyst complementation in Mesp1/2-deficient mice
Y. Abe, T. Sadahiro, R. Fujita, Y. Yamada, T. Akiyama, K. Nakano, S. Honda, Y. Tanimoto, H. Suzuki, S. Mizuno, S. Takahashi, T. Yamaguchi, H. Masaki, K. Hattori, T. Mashimo, M. Ieda
Abstract
Heart transplantation is the only curative option available for patients with advanced heart failure. However, donor organ shortage and graft rejection remain critical challenges in heart transplantation. Blastocyst complementation using pluripotent stem cells (PSCs) can be used to generate organs such as the pancreas and kidneys in animal models with abnormalities in essential developmental genes. Nonetheless, whether functional adult hearts can be generated with blastocyst complementation remains unclear, and it is unknown if parenchyma, blood vessels, and stroma can be generated concomitantly from PSCs using blastocyst complementation to avoid graft rejection. Here, we show the generation of functional adult hearts in acardiac Mesp1 and Mesp2 double-knockout (Mesp1/2-DKO) mice via blastocyst complementation using mouse PSCs. Our result shows that the generated hearts were structurally and functionally normal and restored embryonic lethality in Mesp1/2-DKO mice. All four cardiovascular lineages, including cardiomyocytes, vascular endothelial cells, smooth muscle cells, and cardiac fibroblasts, were virtually entirely derived from exogenous PSCs in the myocardium. Exogenous rat PSCs also generated rat-derived xenogeneic hearts in Mesp1/2-DKO mice via interspecies blastocyst complementation. Thus, blastocyst complementation is a viable technique for generating hearts derived from PSCs and may represent significant progress toward generating rejection-free hearts.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vivo generation of heart and vascular system by blastocyst complementation
G. Coppiello, P. Barlabe, … X. L. Aranguren·bioRxiv·Oct 4, 2022
- Mesendodermal cells fail to contribute to heart formation following blastocyst injection
Biyi Li, Chulan Kwon·Biochemistry and Biophysics ReportsPeer-reviewed·Jun 27, 2025
- Poor survival after myocardial infarction in immune deficient NXG B2m mice is alleviated by transplantation of induced pluripotent stem cell derived cardiomyocytes (iPSC-CM) formulated as spheres, but not single cells
Anne Kathrine Søgaard Terp, Ditte Gry Ellman, … Ditte Caroline Andersen·bioRxiv·Sep 11, 2026
- In situ maturated early-stage human induced pluripotent stem cell-derived cardiomyocytes improve cardiac function by enhancing segmentary contraction in infarcted rats
D. Biagi, E. T. Fantozzi, … R. Dariolli·bioRxiv·Mar 9, 2021
- Macrophage-mediated epimorphosis in pig heart with right ventricular failure
Virginie Lambert, Ambre Deleris, … Michel Pucéat·bioRxiv·Jul 4, 2022
- Myc is dispensable for cardiac development in the mouse but rescues Mycn-deficient hearts through functional replacement and cell competition
Noelia Muñoz-Martín, Rocío Sierra, … Miguel Torres·DevelopmentPeer-reviewed·Jan 14, 2019